Actively Recruiting

Phase Not Applicable
Age: 10Years - 21Years
All Genders
ID05367609

Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

Led by Senthil Sadhasivam · Updated on 2026-04-13

300

Participants Needed

5

Research Sites

26 weeks

Total Duration

On this page

Sponsors

S

Senthil Sadhasivam

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to develop a personalized perioperative precision analgesia platform (PPAP) to improve pain management and reduce serious immediate and long-term adverse effects of opioids in children undergoing painful surgery, specifically posterior spinal fusion. The study explores genetic factors linked to opioid metabolism and response, such as specific gene variants, to better understand risks for respiratory depression, nausea, opioid dependence, and chronic pain after surgery. The study involves approximately 300 children aged 10 to 21 undergoing spine fusion surgery. Participants will have pharmacokinetic blood sampling to measure methadone and oxycodone levels and preoperative genotyping for genes influencing opioid metabolism. Genetic results will not be shared with care providers during treatment to maintain standard prescribing practices while researchers develop personalized dosing guidelines. Participants will be monitored immediately after surgery and up to one year at home for opioid-related side effects and pain relief effectiveness. Assessments include genetic testing, blood sample collection, clinical evaluations, and follow-up on opioid dosing and adverse outcomes. The main outcomes focus on genetic predisposition to opioid adverse effects and pain control, with safety and dosing impact analyzed during the perioperative period.

CONDITIONS

Brief Title

Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

Who Can Participate

Age: 10Years - 21Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children ages 10 to 21 years
  • ASA physical status 1 to 3
  • Undergoing posterior-lateral spinal fusion surgery
  • Receiving inpatient opioid treatment
  • Prescribed opioids at hospital discharge
Not Eligible

You will not qualify if you...

  • Presence of serious illness
  • Severe pain before surgery
  • Preoperative opioid use or misuse

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Preoperative Genotyping

Duration - Up to 1 week before surgery

Participants undergo genetic testing to identify variants affecting opioid metabolism to personalize pain management.

1 visit (in-person) in the pre-operative clinic

Treatment

Duration - Surgery day through post-operative day 4

Participants receive personalized perioperative analgesia during and immediately after spine fusion surgery, including opioid dosing guided by genetic factors.

Inpatient visits during surgery and daily monitoring for up to 4 days

Post-operative Follow-up

Duration - Up to 1 year post-surgery

Participants are monitored at home for long-term opioid-related effects and pain relief for up to 1 year after surgery.

Trial Site Locations

Total: 5 locations

1

University of California

San Francisco, California, United States, 38456

Actively Recruiting

2

Children's Orthopaedic and Scoliosis Surgery Associates, LLP

St. Petersburg, Florida, United States, 33701

Not Yet Recruiting

3

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, United States, 33701

Not Yet Recruiting

4

Riley Children's Hospital

Indianapolis, Indiana, United States, 46202

Actively Recruiting

5

UPMC Children's Hospital

Pittsburgh, Pennsylvania, United States, 15224

Actively Recruiting

Loading map...

Research Team

S

Senthilkumar Sadhasivam, MD, MPH

D

Dayana Alsamsam, BSPS, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Prospective, Randomized Multi-center Study to Assess Magne...

Degenerative Disc Disease

Actively Recruiting

7 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here